Article info

PDF

Original article
Immune activation underlies a sustained clinical response to Yttrium-90 radioembolisation in hepatocellular carcinoma

Authors

  1. Correspondence to Dr Valerie Chew, Translational Immunology Institute (TII), SingHealth-DukeNUS Academic Medical Centre, Singapore; valerie.chew.s.p{at}singhealth.com.sg and Professor Pierce K H Chow, National Cancer Centre, Singapore; pierce.chow.k.h{at}singhealth.com.sg
View Full Text

Citation

Chew V, Lee YH, Pan L, et al
Immune activation underlies a sustained clinical response to Yttrium-90 radioembolisation in hepatocellular carcinoma

Publication history

  • Received October 17, 2017
  • Revised November 29, 2017
  • Accepted December 15, 2017
  • First published February 13, 2018.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.